Project Details
Short title | SCH66336: a Phase II randomised, open-label study of SCH66336 and an Active Reference Agent Gemcitabine in Patients with Metastic Adenocarcinoma of the Pancreas |
---|---|
Status | Finished |
Effective start/end date | 1/03/99 → 30/09/00 |
Funding
- SCHERING-PLOUGH LTD